Literature DB >> 1321879

Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus.

H Iwata1, T Chuma, P Roy.   

Abstract

The sequences of the genes of two of the major capsid proteins of epizootic haemorrhagic disease virus serotype 1 (EHDV-1, Orbivirus genus, Reoviridae) have been determined by analyses of cDNA clones representing the L2 and S7 RNA segments. The EHDV-1 S7 RNA segment, which encodes the VP7 core protein, is 1162 nucleotides in length and has the capacity to encode 349 amino acids (M(r) 38,243). The EHDV-1 L2 RNA segment, which encodes the outer capsid VP2 protein (M(r) 113,249) is 2968 nucleotides in length and has an open reading frame of 971 codons. The potential secondary structure of the EHDV-1 S7 mRNA species, in particular that of the terminal regions, is comparable to those of the corresponding segments of bluetongue virus (BTV) and African horse sickness virus (AHSV); the EHDV-1 L2 mRNA species has a secondary structure similar to that of the L2 mRNA of BTV. The EHDV-1 VP2 and VP7 proteins, as well as those of the other two major structural proteins of EHDV published previously (the inner core VP3 protein and the second outer capsid, VP5), are closely related to the corresponding proteins of BTV. The EHDV and BTV VP7 sequences are more distantly related to the sequence of the AHSV VP7 protein published recently.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321879     DOI: 10.1099/0022-1317-73-4-915

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

2.  Production of a recombinant major inner capsid protein for serological detection of epizootic hemorrhagic disease virus.

Authors:  Lizhong Luo; Marta I Sabara
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

3.  Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assembly.

Authors:  C K Limn; N Staeuber; K Monastyrskaya; P Gouet; P Roy
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7.

Authors:  A K Basak; P Gouet; J Grimes; P Roy; D Stuart
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  RT-PCR assays for seven serotypes of epizootic haemorrhagic disease virus & their use to type strains from the Mediterranean region and North America.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Donna J Johnson; Mehdi El Harrak; Hafsa Madani; Hagai Yadin; Serife Incoglu; Kadir Yesilbag; Andrew B Allison; David E Stallknecht; Carrie Batten; Simon J Anthony; Peter P C Mertens
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

6.  Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA.

Authors:  M Cloete; D H du Plessis; A A van Dijk; H Huismans; G J Viljoen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Development of polymerase chain reaction for specific identification of epizootic hemorrhagic disease virus serotype 1.

Authors:  I E Aradaib; J W McBride; W C Wilson; B I Osburn
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  A single point mutation in the VP7 major core protein of bluetongue virus prevents the formation of core-like particles.

Authors:  H Le Blois; P Roy
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.

Authors:  Valeria Lulla; Aleksei Lulla; Kerstin Wernike; Andrea Aebischer; Martin Beer; Polly Roy
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.